ASMB

ASSEMBLY BIOSCIENCES INC

ASMB·045396207·US·Common Stock·Healthcare - Biotechnology-Activist

ASMB (ASSEMBLY BIOSCIENCES INC) is held by 52 institutional investors as of Q1 2026. Largest holders: FARALLON CAPITAL MANAGEMENT, L.L.C. ($34.1M), RA CAPITAL MANAGEMENT, L.P. ($28.3M), Janus Henderson Group Ltd. ($23.5M). Net institutional sentiment: Mixed.

52
Holders
Avg rating(8 Elite)
$169.4M
Total Value
64% (57)
Fund Consensus
32 buying - 18 selling
ASMBSmart Money Verdict
View all
Held by 52 funds
8 elite
Who's Trading
ActivistGSGILEAD SCIENCES, INC.25.1%May 27, 2026
ActivistPBParadigm BioCapital Advisors LP5.4%May 11, 2026
InsiderWSWhite Nicole SSell $5KMar 30, 2026
InsiderWSWhite Nicole SSell $247.41Mar 30, 2026
InsiderBMBjorkquist Jeanette MSell $8KMar 30, 2026
InsiderBMBjorkquist Jeanette MSell $439.84Mar 30, 2026
ActivistFAFarallon Capital Partners, L.P.1.5%Feb 9, 2026
ActivistJANUS HENDERSON GROUP PLCJANUS HENDERSON GROUP PLC8.2%Dec 8, 2025
ActivistASAlexander Schornstein3.5%Aug 18, 2025
ActivistRA Capital Management, L.P.RA Capital Management, L.P.9.5%Aug 18, 2025
13F: Insider & Congress:
Fund
Action
Shares
Value
Weight
Est. P&L
Conviction
Unchanged
1.2M$34.1M0.2%+11.25%
0
Unchanged
1M$28.3M0.3%+11.25%
0
Increased
849,309(+1.4%)$23.5M0.0%+7.71%
29
New
490,447$13.6M0.0%-4.86%
39
Decreased
344,105(-42.7%)$9.5M0.0%-3.63%
0
Decreased
296,855(-6.9%)$8.2M0.0%+11.25%
0
Increased
233,650(+137.9%)$6.5M0.0%-7.14%
44
Increased
202,743(+5.4%)$5.6M0.0%+24.97%
29
Increased
163,400(+26.6%)$4.5M0.0%-0.43%
33
Unchanged
161,000$4.5M0.0%-14.72%
0
Increased
132,971(+1.3%)$3.7M0.0%-46.28%
27
Increased
120,500(+122.2%)$3.3M0.0%+1.77%
43
Decreased
81,841(-23.2%)$2.3M0.0%-14.72%
0
New
71,606$2M0.0%-4.86%
36
Increased
69,256(+64.2%)$1.9M0.0%-7.54%
38
Increased
56,689(+7.0%)$1.6M0.0%+21.74%
27
Increased
53,962(+12.1%)$1.4M0.0%-13.75%
29
Decreased
41,014(-0.5%)$1.1M0.0%-47.07%
0
Increased
39,446(+4.3%)$1.1M0.0%-14.35%
26
Increased
36,205(+4.1%)$1M0.0%-3.33%
26

Showing 1-20 of 57

1 / 3

Other Healthcare stocks held by institutions

Data sourced from four SEC data sources: 13F, Form 4, 13D/13G, and STOCK Act. Not financial advice. Full disclaimer

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used